1 Min Read
March 28 (Reuters) - Cynata Therapeutics Ltd:
* UNITED STATES FDA GRANTED CYNATA ORPHAN DRUG DESIGNATION FOR CYP-001 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.